TrademarkOpen
Search / United States / 97273425

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

VOBRIG

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical preparations, namely, hormone modifying agents; pharmaceutical preparations for the treatment of cancer…
Show more

Pharmaceutical preparations, namely, hormone modifying agents; pharmaceutical preparations for the treatment of cancer, central precocious puberty, endometriosis

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 22 Feb 2022
    Application filed
    New Application Entered
  2. 23 Sep 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 24 Sep 2022
    Examination suspended
    Suspension Letter Written
  4. 20 Mar 2024
    Approved for publication
    Approved For Pub - Principal Register
  5. 23 Apr 2024
    Published for opposition
    Published For Opposition
  6. 18 Jun 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  7. 10 Dec 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 29 May 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  9. 9 Dec 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 35 events
2026-05-28Notice Of Approval Of Extension Request E-Mailed
2026-05-27Sou Teas Extension Received
2026-05-27Sou Extension 4 Filed
2026-05-27Sou Extension 4 Granted
2025-12-10Notice Of Approval Of Extension Request E-Mailed
2025-12-09Sou Teas Extension Received
2025-12-09Sou Extension 3 Filed
2025-12-09Sou Extension 3 Granted
2025-09-15Notice Of Approval Of Extension Request E-Mailed
2025-05-29Sou Teas Extension Received
2025-05-29Sou Extension 2 Filed
2025-05-29Sou Extension 2 Granted
2025-03-03Notice Of Approval Of Extension Request E-Mailed
2024-12-10Sou Teas Extension Received
2024-12-10Sou Extension 1 Filed
2024-12-10Sou Extension 1 Granted
2024-06-18Noa Mailed - Sou Required From Applicant
2024-04-23Published For Opposition
2024-04-23Official Gazette Publication Confirmation E-Mailed
2024-04-03Notification Of Notice Of Publication E-Mailed
2024-03-20Approved For Pub - Principal Register
2024-01-12Correspondence Received In Law Office
2024-01-12Teas/Email Correspondence Entered
2024-01-11Assigned To Lie
2023-08-21Teas Response To Suspension Inquiry Received
2023-06-17Inquiry As To Suspension Mailed
2023-06-17Inquiry To Suspension E-Mailed
2023-06-17Notification Of Inquiry As To Suspension E-Mailed
2023-04-10Suspension Checked - To Attorney For Action
2022-09-24Suspension Letter Written
2022-09-24Letter Of Suspension E-Mailed
2022-09-24Notification Of Letter Of Suspension E-Mailed
2022-09-23Assigned To Examiner
2022-02-23New Application Office Supplied Data Entered
2022-02-22New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations, namely, hormone modifying agents; pharmaceutical preparations for the treatment of cancer, central precocious puberty, endometriosis

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 29 May 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.